The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial
Open accessAbstract
BACKGROUND: Allergen-specific immunotherapy represents the only disease-modifying treatment for allergic diseases. We and others have previously demonstrated that intralymphatic immunotherapy (ILIT), a less time-consuming alternative to conventional subcutaneous immunotherapy (SCIT), is safe and effective. However, this has recently been disputed. The aim of this study was therefore to expand our previous trial, further assessing the safety and efficacy of ILIT. METHODS: Thirty-six patients with pollen-induced rhinoconjunctivitis were randomised to receive three intralymphatic inguinal injections of active allergen (1000 SQ-U birch- or grass-pollen) or placebo. Clinical effects, safety and circulating immunological markers were assessed before, 4 weeks after treatment and at the end of the consecutive pollen season. RESULTS: No moderate or severe reactions were recorded following ILIT. Patients receiving active ILIT experienced a significant improvement in self-recorded seasonal allergic symptoms, as compared to placebo (p = 0.05). In a subgroup of these patients ("improved"), a reduction in nasal symptoms following nasal allergen provocation was also demonstrated. No changes in total IgE or IgG4 were found. However, the affinity of allergen specific IgG4 following active treatment was significantly increased, as compared to non-improved patients (p = 0.04). This could be correlated with clinical improvement, on an individual level. CONCLUSIONS: This double-blinded placebo-controlled study confirms that ILIT is a safe and effective treatment for pollen-induced rhinoconjunctivitis, markedly reducing seasonal allergic symptoms. TRIAL REGISTRATION: EudraCT: 2009-016815-39.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Of the 6 trials published thus far, 5 have demonstrated clinical efficacy and safety.1716-1720”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1719]
The cited source says what the claim attributes to it.
In the citing paper
“Most trials1716,1718-1721 used commercially available grass pollen or birch pollen allergen extract as the antigen.”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1719]
The cited source says what the claim attributes to it.
In the citing paper
“Clinical trials have illustrated that a reduction in AR symptoms can be achieved with just 3 doses of injected allergen, with a dosage interval of 1 month1716-1720 (Table IX.D.6).”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1719]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of allergen-specific immunotherapy
Akdis, C. A., & Akdis, M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.030 · Cited by 803
Senti, G., Prinz Vavricka, B. M., Erdmann, I., Diaz, M. I., Markus, R., McCormack, S. J., Simard, J. J., Wüthrich, B., Crameri, R., Graf, N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803725105 · Cited by 364
Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens
Akdis, C. A., & Akdis, M. (2015) · World Allergy Organization Journal · doi:10.1186/s40413-015-0063-2 · Cited by 361
Mechanisms of allergen-specific immunotherapy
Akdis, M., & Akdis, C. A. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.01.022 · Cited by 301
Shamji, M. H., Ljørring, C., Francis, J. N., A Calderon, M., Larché, M., Kimber, I., Frew, A. J., Ipsen, H., Lund, K., Würtzen, P. A., et al. (2012) · Allergy · doi:10.1111/j.1398-9995.2011.02745.x · Cited by 297
Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections
Senti, G., Crameri, R., Kuster, D., Johansen, P., Martinez-Gomez, J. M., Graf, N., Steiner, M., Hothorn, L. A., Grönlund, H., Tivig, C., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.02.026 · Cited by 271
Global Alliance against Chronic Respiratory Diseases
Bousquet, J., Dahl, R., & Khaltaev, N. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01307.x · Cited by 248
Epitope dominance, competition and T cell affinity maturation
Kedl, R. M., Kappler, J. W., & Marrack, P. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00009-2 · Cited by 209
Mechanisms of immunotherapy: IgG revisited
Wachholz, P. A., & Durham, S. R. (2004) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/01.all.0000136753.35948.c0 · Cited by 195
Senti, G., von Moos, S., Tay, F., Graf, N., Sonderegger, T., Johansen, P., & Kündig, T. M. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.08.036 · Cited by 158
Cited by
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta‐analysis
Dhami, S., Nurmatov, U., Arasi, S., Khan, T., Asaria, M., Zaman, H., Agarwal, A., Netuveli, G., Roberts, G., Pfaar, O., et al. (2017) · Allergy · doi:10.1111/all.13201 · Cited by 369
“RESULTS Effectiveness Description of trials We identified 61 SCIT RCTs (reported in 63 papers) (19–81) including 6,379 patients, 71 SLIT RCTs (reported in 75 papers) ) (82–119,119–121,121–156) including 13,636 patients and two ILIT RCTs (157,158) including 56 patients (Tables 1a-c).”
BackgroundAkdis (2020) · doi:10.1111/pai.13189 · Cited by 320
Berings, M., Karaaslan, Ç., Altunbulakli, C., Gevaert, P., Akdiş, M., Bachert, C., & Akdiş, C. A. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.08.025 · Cited by 119
Metadata
- Authors
- Hylander, T., Larsson, O., Petersson-Westin, U., Eriksson, M., Kumlien Georén, S., Winqvist, O., & Cardell, L.-O.
- Affiliations
- Karolinska Institutet (SE)
- Lund University (SE)
- Karolinska University Hospital (SE)
- Corresponding author
- Cardell, Lars-Olaf
- Venue
- Respiratory Research
- Published
- 2016-01-27
- Volume
- 17
- Issue
- 1
- Pages
- 10-10
- ISSN
- 1465-9921 (ISSN-L)
- 1465-993X
- PMC
- PMC4728811
- OpenAlex
- W2269234188
- Cited by
- 92
- References
- 24
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 4 · 2023: 12 · 2022: 12 · 2021: 9 · 2020: 20 · 2019: 4 · 2018: 11 · 2017: 9 · 2016: 5
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Respiratory Research (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- intralymphatic immunotherapy, allergen immunotherapy, birch pollen, grass pollen, allergen-specific IgG4, IgE, treatment safety
- MeSH terms
- Adult, Allergens, Conjunctivitis, Desensitization, Immunologic, Double-Blind Method, Female, Rhinitis, Allergic, Seasonal, Humans, Injections, Intralymphatic, Male, Middle Aged, Placebo Effect, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial. https://app.cochat.ai/papers/10.1186/s12931-016-0324-9
- The paper
- Hylander, T., Larsson, O., Petersson-Westin, U., Eriksson, M., Kumlien Georén, S., Winqvist, O., & Cardell, L.-O. (2016). Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial. Respiratory Research. https://doi.org/10.1186/s12931-016-0324-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.